Patent US2366569A successfully refreshed from Google Patents.
Patent US2769345A successfully refreshed from Google Patents.
US4642292A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for isolation of connective tissue biomatrix
Assignee: Albert Einstein College of Medicine
•
Filing: 1983-06-06
•
Granted: 1987-02-10
•
Expires: 2003-06-06
Abstract
Abstract A method is disclosed for isolation of connective tissue fibers, called biomatrix, containing a significant portion of the extracellular matrix, i.e., basement membrane components and components of the ground substance. The connective tissue fibers isolated by this method provide significantly higher survival and attachment rates, and often significantly improved growth properties, for in vitro cultures of differentiated cells, especially epithelial cells, over current culture substrates which do not contain these fibers.
Inventors
- 👤 Lola C. M. Reid
- 👤 Marcos Rojkind
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 17:17
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/0068; C12N2533/00; C12N2533/90
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
151 words
A method for the preparation, isolation and use of connective tissue-derived fibers as a substrate in a cell culture of viable and functional differentiated cells comprising the steps of: a. dispersing tissue to form a suspension of connective tissue-derived fibrous solids; b. separating the connective tissue-derived fibrous solids out of the suspension of step a and adding said solids to a delipidation solution; c. separating the connective tissue-derived fibrous solids out of the solution of step b and adding said solids to a saline solution containing DNase and Ribonuclease; d. separating the connective tissue-derived fibrous solids out of the solution of step c; e. rinsing said connective tissue-derived fibrous solids, first with a saline solution and then with the solution to be used in the cell culture; and f. utilizing the connective tissue-derived fibrous solids of step e as a substrate in a cell culture of viable and functional differentiated cells.
Claim 2
Independent Claim
151 words
A method for the preparation, isolation and use of connective tissue-derived fibers as a substrate in a cell culture of viable and functional differentiated cells comprising the steps of: a. dispersing tissue to form a suspension of connective tissue-derived fibrous solids; b. separating the connective tissue-derived fibrous solids out of the suspension of step a and adding said solids to a delipidation solution; c. separating the connective tissue-derived fibrous solids out of the solution of step b and adding said solids to a saline solution containing DNase and Ribonuclease; d. separating the connective tissue-derived fibrous solids out of the solution of step c; e. rinsing said connective tissue-derived fibrous solids, first with a saline solution and then with the solution to be used in the cell culture; and f. utilizing the connective tissue-derived fibrous solids of step e as a substrate in a cell culture of viable and functional differentiated cells.
Claim 3
Dependent Claim
15 words
The method of claim 1, wherein the separating of the solution components is by filtration.
Claim 4
Dependent Claim
15 words
The method of claim 1, wherein the separating of the solution components is by centrifugation.
Claim 5
Dependent Claim
25 words
The method of claim 1, wherein the connective tissue-derived fibrous solids of step e are stored frozen in a saline solution with a cryoprotective agent.
Claim 6
Dependent Claim
23 words
The method of claim 1, wherein the connective tissue-derived fibrous solids of step e are sterilized and then stored at temperatures above freezing.
Claim 7
Dependent Claim
12 words
The method of claim 1, wherein the saline solution is 0.1-1.0M NaCl.
Claim 8
Dependent Claim
22 words
The method of claim 1, wherein the solution to be used in the cell culture of step e is a serum-free medium.
Claim 9
Dependent Claim
18 words
The method of claim 1, wherein the delipidation solution of step b is about a 40:60 Butanol/ether solution.
Claim 10
Independent Claim
195 words
A method for the preparation, isolation and use of connective tissue-derived fibers containing a significant portion of the extracellular matrix and a plurality of collagen types, for use as a substrate in a cell culture of viable and functional differentiated cells, comprising the steps of: a. dispersing tissue to form a suspension of connective tissue-derived fibrous solids; b. separating the connective tissue-derived fibrous solids out of the suspension of step a and adding said solids to a delipidation solution selected from the group consisting of a detergent and a Butanol/ether mixture; c. separating the connective tissue-derived fibrous solids out of the solution of step b and adding said solids to a saline solution containing DNase and Ribonuclease at a ratio of addition of about 1 mg of DNase and about 5 mg of Ribonuclease per fifty ml of serum-free medium; d. separating the connective tissue-derived fibrous solids out of the solution of step c; e. rinsing said solids, first with saline solution, and then with the solution to be used in the cell culture; and f. utilizing the solids of step e as a substrate in a cell culture of viable and functional differentiated cells.
Claim 11
Independent Claim
195 words
A method for the preparation, isolation and use of connective tissue-derived fibers containing a significant portion of the extracellular matrix and a plurality of collagen types, for use as a substrate in a cell culture of viable and functional differentiated cells, comprising the steps of: a. dispersing tissue to form a suspension of connective tissue-derived fibrous solids; b. separating the connective tissue-derived fibrous solids out of the suspension of step a and adding said solids to a delipidation solution selected from the group consisting of a detergent and a Butanol/ether mixture; c. separating the connective tissue-derived fibrous solids out of the solution of step b and adding said solids to a saline solution containing DNase and Ribonuclease at a ratio of addition of about 1 mg of DNase and about 5 mg of Ribonuclease per fifty ml of serum-free medium; d. separating the connective tissue-derived fibrous solids out of the solution of step c; e. rinsing said solids, first with saline solution, and then with the solution to be used in the cell culture; and f. utilizing the solids of step e as a substrate in a cell culture of viable and functional differentiated cells.
Claim 12
Dependent Claim
12 words
The method of claim 9 wherein, the differentiated cells are epithelial cells.
Claim 13
Dependent Claim
11 words
The method of claim 9, wherein the differentiated cells are hepatocytes.
Claim 14
Dependent Claim
19 words
The method of claim 9 wherein, the extracellular matrix comprises basement membrane components and components of the ground substance.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-02-09 | 1990-08-11 | 1991-02-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-02-09 | 1994-08-11 | 1995-02-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-02-09 | 1998-08-11 | 1999-02-10 | $7700.00 | Window Closed / Lapsed |